Register for our free email digests:
Division of Novacyt SA
Latest From Merz Pharmaceuticals GMBH
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Keeping Track Of New Drugs: US FDA Review Queue Adds Spark Gene Therapy, Amgen Migraine Antibody, Bayer Oncologic
The latest news about novel agent applications from our FDA Performance Tracker.
Despite many restrictions, the nation is a potential market for imported drugs.
Weekly column reviews the latest drug development news from our FDA Performance Tracker. This week: updates on AbbVie's HCV franchise, Merck's Keytruda and a PD-L1 companion diagnostic, and botulinum toxins from Merz and Actavis.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
- Therapeutic Areas
- Infectious & Viral Diseases
- Western Europe
- Parent & Subsidiaries
- Novacyt SA
- Senior Management
Spencer Kerry, CFO
Gil Morgan, Chief Dev. Officer
John W Thornback, CBO
- Contact Info
Phone: (44) (0)161 998 7239
South Ct., Sharston Rd.
Manchester, M22 4SN
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.